These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 34067285)

  • 1. Significance of the Gut Microbiota in Acute Kidney Injury.
    Kobayashi T; Iwata Y; Nakade Y; Wada T
    Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34067285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal microbiota dysbiosis in acute kidney injury: novel insights into mechanisms and promising therapeutic strategies.
    Lei J; Xie Y; Sheng J; Song J
    Ren Fail; 2022 Dec; 44(1):571-580. PubMed ID: 35350960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research progress in the role of gut microbiota in acute kidney injury.
    Chen T; Chang C; Hou B; Qiu L; Sun H; Zhu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 49(3):385-391. PubMed ID: 38970512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota-derived D-serine protects against acute kidney injury.
    Nakade Y; Iwata Y; Furuichi K; Mita M; Hamase K; Konno R; Miyake T; Sakai N; Kitajima S; Toyama T; Shinozaki Y; Sagara A; Miyagawa T; Hara A; Shimizu M; Kamikawa Y; Sato K; Oshima M; Yoneda-Nakagawa S; Yamamura Y; Kaneko S; Miyamoto T; Katane M; Homma H; Morita H; Suda W; Hattori M; Wada T
    JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota-Kidney Cross-Talk in Acute Kidney Injury.
    Gong J; Noel S; Pluznick JL; Hamad ARA; Rabb H
    Semin Nephrol; 2019 Jan; 39(1):107-116. PubMed ID: 30606403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Kidney Injury and Gut Dysbiosis: A Narrative Review Focus on Pathophysiology and Treatment.
    Chou YT; Kan WC; Shiao CC
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota Mediates the Protective Effects of Traditional Chinese Medicine Formula Qiong-Yu-Gao against Cisplatin-Induced Acute Kidney Injury.
    Zou YT; Zhou J; Zhu JH; Wu CY; Shen H; Zhang W; Zhou SS; Xu JD; Mao Q; Zhang YQ; Long F; Li SL
    Microbiol Spectr; 2022 Jun; 10(3):e0075922. PubMed ID: 35481834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiome and AKI: Roles of the Immune System and Short-Chain Fatty Acids.
    Gharaie S; Noel S; Rabb H
    Nephron; 2020; 144(12):662-664. PubMed ID: 32721962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal microbiota control acute kidney injury severity by immune modulation.
    Yang J; Kim CJ; Go YS; Lee HY; Kim MG; Oh SW; Cho WY; Im SH; Jo SK
    Kidney Int; 2020 Oct; 98(4):932-946. PubMed ID: 32470493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota dysbiosis in AKI to CKD transition.
    Saranya GR; Viswanathan P
    Biomed Pharmacother; 2023 May; 161():114447. PubMed ID: 37002571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal Microbiota in Experimental Acute Kidney Injury.
    Shah N; Rabb H
    Nephron; 2023; 147(1):25-30. PubMed ID: 36195072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic interplay between gut microbiome and plasma metabolome in cardiac surgery-associated acute kidney injury.
    Bai Y; Huang W; Jiang X; Xu W; Li Y; Wang Y; Huang S; Wu K; Hu L; Chen C
    Rapid Commun Mass Spectrom; 2023 Jun; 37(11):e9504. PubMed ID: 36918294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of colon C5a/C5a receptor signalling pathway confers protection against LPS-induced acute kidney injury via gut microbiota-kidney axis.
    Xie RC; Zhang JC; Lin XM; Huang T; Wang YT; Zhang LF; Hong XY; Lin XF; Zheng HJ; Luo Z; Yi LT; Ma JF
    Eur J Pharmacol; 2024 Apr; 969():176425. PubMed ID: 38387717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of short-chain fatty acids in kidney injury induced by gut-derived inflammatory response.
    Huang W; Zhou L; Guo H; Xu Y; Xu Y
    Metabolism; 2017 Mar; 68():20-30. PubMed ID: 28183450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Microbiome and Acute Kidney Injury.
    Rabb H; Pluznick J; Noel S
    Nephron; 2018; 140(2):120-123. PubMed ID: 29961049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating gut microbiota-blood and urine metabolite correlations in early sepsis-induced acute kidney injury: insights from targeted KEGG analyses.
    Xu Y; Xu J; Zhu Y; Mao H; Li J; Kong X; Zhu X; Zhang J
    Front Cell Infect Microbiol; 2024; 14():1375874. PubMed ID: 38887493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota and neonatal acute kidney injury biomarkers.
    Yang K; Du G; Liu J; Zhao S; Dong W
    Pediatr Nephrol; 2023 Nov; 38(11):3529-3547. PubMed ID: 36997773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: Effect of Gut Microbiota and Its Metabolite SCFAs on Radiation-Induced Intestinal Injury.
    Li Y; Zhang Y; Wei K; He J; Ding N; Hua J; Zhou T; Niu F; Zhou G; Shi T; Zhang L; Liu Y
    Front Cell Infect Microbiol; 2021; 11():577236. PubMed ID: 34307184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.